These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 18539964)

  • 1. Mathematical models of cancer stem cells.
    Michor F
    J Clin Oncol; 2008 Jun; 26(17):2854-61. PubMed ID: 18539964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative approaches to analyzing imatinib-treated chronic myeloid leukemia.
    Michor F
    Trends Pharmacol Sci; 2007 May; 28(5):197-9. PubMed ID: 17412430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic myeloid leukemia stem cells.
    Kavalerchik E; Goff D; Jamieson CH
    J Clin Oncol; 2008 Jun; 26(17):2911-5. PubMed ID: 18539972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer biology: summing up cancer stem cells.
    Huntly BJ; Gilliland DG
    Nature; 2005 Jun; 435(7046):1169-70. PubMed ID: 15988505
    [No Abstract]   [Full Text] [Related]  

  • 5. Imatinib-resistant lymphoid clone of chronic myelogenous leukemia in blast phase arising from B cell-committed progenitor leukemic stem cells.
    Kobayashi S; Sato K; Kobayashi A; Osawa Y; Nakamura Y; Kimura F
    Ann Hematol; 2011 Mar; 90(3):367-8. PubMed ID: 20556391
    [No Abstract]   [Full Text] [Related]  

  • 6. A PDE model for imatinib-treated chronic myelogenous leukemia.
    Kim PS; Lee PP; Levy D
    Bull Math Biol; 2008 Oct; 70(7):1994-2016. PubMed ID: 18663536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of chronic myeloid leukaemia.
    Michor F; Hughes TP; Iwasa Y; Branford S; Shah NP; Sawyers CL; Nowak MA
    Nature; 2005 Jun; 435(7046):1267-70. PubMed ID: 15988530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cancer initiation as mini-evolution].
    Iwasa Y
    Tanpakushitsu Kakusan Koso; 2005 Dec; 50(15):1962-9. PubMed ID: 16363646
    [No Abstract]   [Full Text] [Related]  

  • 9. Stem cell regulation and the development of blast crisis in chronic myeloid leukemia: Implications for the outcome of Imatinib treatment and discontinuation.
    Wodarz D
    Med Hypotheses; 2008; 70(1):128-36. PubMed ID: 17566666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal control for resistance and suboptimal response in CML.
    Aïnseba B; Benosman C
    Math Biosci; 2010 Oct; 227(2):81-93. PubMed ID: 20638391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation therapy as an effective strategy for the treatment of chronic myelogenous leukemia.
    Moosavi MA; Yazdanparast R
    Med Hypotheses; 2006; 67(6):1470-1. PubMed ID: 16919395
    [No Abstract]   [Full Text] [Related]  

  • 12. Strategies to eliminate cancer stem cells: clinical implications.
    Huff CA; Matsui WH; Smith BD; Jones RJ
    Eur J Cancer; 2006 Jun; 42(9):1293-7. PubMed ID: 16644203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
    Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Getting to the stem of chronic myeloid leukaemia.
    Savona M; Talpaz M
    Nat Rev Cancer; 2008 May; 8(5):341-50. PubMed ID: 18385684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Circumventing resistance to imatinib therapy in chronic myeloid leukemia].
    Minami Y; Naoe T
    Gan To Kagaku Ryoho; 2009 Apr; 36(4):544-7. PubMed ID: 19381024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted cancer therapy: promise and reality.
    Klein S; Levitzki A
    Adv Cancer Res; 2007; 97():295-319. PubMed ID: 17419951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imatinib resistance and progression of CML to blast crisis: somatic hypermutation AIDing the way.
    Strout MP; Schatz DG
    Cancer Cell; 2009 Sep; 16(3):174-6. PubMed ID: 19732715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer treatment in the STI571 era: what will change?
    Sawyers CL
    J Clin Oncol; 2001 Sep; 19(18 Suppl):13S-16S. PubMed ID: 11560965
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic myeloid leukemia blast crisis arises from progenitors.
    Michor F
    Stem Cells; 2007 May; 25(5):1114-8. PubMed ID: 17218393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential development of mutant clones in an imatinib resistant chronic myeloid leukaemia patient following sequential treatment with multiple tyrosine kinase inhibitors: an emerging problem?
    Breccia M; Frustaci AM; Cannella L; Soverini S; Stefanizzi C; Federico V; Grammatico S; Santopietro M; Alimena G
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):195-7. PubMed ID: 19156415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.